Your search history is turned on.
Date: April 24, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
AVIVAGEN ANNOUNCES RESULTS OF AGM APRIL 19 2023 FINAL VERSION For Immediate Release Avivagen Makes Voluntary Assignment into Bankruptcy under the BIA Ottawa, ON /Business Wire/ April 24, 2024 /Avivagen Inc. (TSXV:VIV) (Avivagen or the Company), a life sciences corporation focused on developing and commercializing products for livestock, compani...
Date: October 17, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Avivagen Announces New 500Kg Order for OxC-beta Avivagen Announces New 500Kg Order for OxC-beta OTTAWA, Ontario--(BUSINESS WIRE)--October 17, 2023--Avivagen Inc. (TSXV.VIV) (Avivagen or the Company), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance...
Date: September 29, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2023 Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2023 OTTAWA, Ontario--(BUSINESS WIRE)--September 29, 2023--Avivagen Inc. (TSXV:VIV) (Avivagen), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human...
Date: September 28, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Ira Levy, Chief Financial Officer of Avivagen Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Avivagen Inc., (the issuer) for the interim period ended July 31, 2023. 2. No misrepresent...
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Kym Anthony, Chief Executive Officer of Avivagen Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Avivagen Inc., (the issuer) for the interim period ended July 31, 2023. 2. No misreprese...
SUMMARY FINANCIAL INFORMATION AND MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Page 1 of 25 September 28, 2023 Statement of Management Responsibility The following Summary Financial Information and Managements Discussion and Analysis of Financial Condition and Results of Operations (MD&A) for the three- and nine-month p...
Avivagen Inc. Page 1 of 30 Avivagen Inc. Financial Statements July 31, 2023 Managements Statement of Responsibility The financial statements of Avivagen Inc. have been prepared by management in accordance with International Financial Reporting Standards (IFRS). Financial statements are not precise, since they include certain amounts based on estimates and judg...
Date: February 21, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, _______________________, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission...
Avivagen Inc. Page 1 of 33 Avivagen Inc. Financial Statements October 31, 2022 Managements Statement of Responsibility The financial statements of Avivagen Inc. have been prepared by management in accordance with International Financial Reporting Standards (IFRS). Financial statements are not precise, since they include certain amounts based on estimates and j...
Microsoft Word - ASC_LIB1-#5334409-v1-13-501_F1_Consolidation_Eff_Mar_1_2017.DOCX Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 RE...